Literature DB >> 25129052

Epidemiology of MPN: what do we know?

L A Anderson1, M F McMullin.   

Abstract

The myeloproliferative neoplasms, are characterised by overproduction of myeloid cells. Chronic myeloid leukaemia, polycythaemia vera, essential thrombocythaemia, myelofibrosis and the very rare disorders chronic neutrophilic leukaemia, chronic eosinophilic leukaemia not otherwise specified and mastocytosis are all included in the group. Incidence and prevalence rates reported in the worldwide literature are presented in this review. Survival data on each condition is described. Information on the aetiology of the disorders is discussed including body mass index, diet, smoking and alcohol, allergies, associated medical conditions, occupation and environmental exposures with focus on recent new studies. The aetiology of the myeloproliferative neoplasms remains unknown, and this review of the current state of knowledge highlights the need for further comprehensive research.

Entities:  

Mesh:

Year:  2014        PMID: 25129052     DOI: 10.1007/s11899-014-0228-z

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   3.952


  102 in total

1.  Occupational benzene exposure and the risk of chronic myeloid leukemia: a meta-analysis of cohort studies incorporating study quality dimensions.

Authors:  Jelle Vlaanderen; Qing Lan; Hans Kromhout; Nathaniel Rothman; Roel Vermeulen
Journal:  Am J Ind Med       Date:  2012-06-21       Impact factor: 2.214

2.  Alcohol consumption and risk of leukemia: A multicenter case-control study.

Authors:  Giuseppe Gorini; Emanuele Stagnaro; Vincenzo Fontana; Lucia Miligi; Valerio Ramazzotti; Oriana Nanni; Stefania Rodella; Rosario Tumino; Paolo Crosignani; Carla Vindigni; Arabella Fontana; Paolo Vineis; Adele Seniori Costantini
Journal:  Leuk Res       Date:  2006-08-17       Impact factor: 3.156

3.  [Leukemia incidence and survival in Germany according to current standardized categories].

Authors:  A Nennecke; A Wienecke; K Kraywinkel
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2014-01       Impact factor: 1.513

4.  Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms.

Authors:  Animesh Pardanani; Terra L Lasho; Christy M Finke; S Vincent Rajkumar; Preet Paul Singh; Rhett P Ketterling; Curtis A Hanson; Jerry A Katzmann; Ayalew Tefferi
Journal:  J Clin Oncol       Date:  2012-02-13       Impact factor: 44.544

5.  Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.

Authors:  Milena Sant; Claudia Allemani; Carmen Tereanu; Roberta De Angelis; Riccardo Capocaccia; Otto Visser; Rafael Marcos-Gragera; Marc Maynadié; Arianna Simonetti; Jean-Michel Lutz; Franco Berrino
Journal:  Blood       Date:  2010-07-27       Impact factor: 22.113

6.  Are occupational, hobby, or lifestyle exposures associated with Philadelphia chromosome positive chronic myeloid leukaemia?

Authors:  J Björk; M Albin; H Welinder; H Tinnerberg; N Mauritzson; T Kauppinen; U Strömberg; B Johansson; R Billström; Z Mikoczy; T Ahlgren; P G Nilsson; F Mitelman; L Hagmar
Journal:  Occup Environ Med       Date:  2001-11       Impact factor: 4.402

7.  Anthropometric characteristics and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Fatemeh Saberi Hosnijeh; Isabelle Romieu; Valentina Gallo; Elio Riboli; Anne Tjønneland; Jytte Halkjær; Guy Fagherazzi; Françoise Clavel-Chapelon; Laure Dossus; Annie Lukanova; Rudolf Kaaks; Antonia Trichopoulou; Pagona Lagiou; Michael Katsoulis; Salvatore Panico; Giovanna Tagliabue; Catalina Bonet; Miren Dorronsoro; José María Huerta; Eva Ardanaz; Maria-José Sánchez; Dorthe Johansen; Signe Borgquist; Petra Peeters; H Bas Bueno-de-Mesquita; Martine M Ros; Ruth C Travis; Timothy J Key; Paolo Vineis; Roel Vermeulen
Journal:  Cancer Causes Control       Date:  2013-01-04       Impact factor: 2.506

8.  Associations between allergies and risk of hematologic malignancies: results from the VITamins and lifestyle cohort study.

Authors:  Mazyar Shadman; Emily White; Anneclaire J De Roos; Roland B Walter
Journal:  Am J Hematol       Date:  2013-12       Impact factor: 10.047

9.  Epidemiological data in polycythaemia vera: a study of 842 cases.

Authors:  Y Najean; J D Rain; C Billotey
Journal:  Hematol Cell Ther       Date:  1998-08

10.  Risk of adult acute and chronic myeloid leukemia with cigarette smoking and cessation.

Authors:  Jessica R B Musselman; Cindy K Blair; James R Cerhan; Phuong Nguyen; Betsy Hirsch; Julie A Ross
Journal:  Cancer Epidemiol       Date:  2013-05-02       Impact factor: 2.984

View more
  8 in total

1.  Incidence of myeloproliferative neoplasms - trends by subgroup and age in a population-based study in Sweden.

Authors:  M Hultcrantz; A Ravn Landtblom; B Andréasson; J Samuelsson; P W Dickman; S Y Kristinsson; M Björkholm; T M-L Andersson
Journal:  J Intern Med       Date:  2020-01-11       Impact factor: 8.989

Review 2.  Polycythemia Vera.

Authors:  Jerry L Spivak
Journal:  Curr Treat Options Oncol       Date:  2018-03-07

Review 3.  Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender.

Authors:  Jeffrey Patterson-Fortin; Alison R Moliterno
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

4.  Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973-2011.

Authors:  Melissa A Deadmond; Julie A Smith-Gagen
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-13       Impact factor: 4.553

Review 5.  A comprehensive review of pacritinib in myelofibrosis.

Authors:  Srdan Verstovsek; Rami S Komrokji
Journal:  Future Oncol       Date:  2015-09-14       Impact factor: 3.404

6.  Expression profiles analysis identifies specific interferon-stimulated signatures as potential diagnostic and predictive indicators of JAK2V617F + myelofibrosis.

Authors:  Yanhong Zhao; Di Wang; Yipeng Liang; Changlu Xu; Lihong Shi; Jingyuan Tong
Journal:  Front Genet       Date:  2022-08-18       Impact factor: 4.772

7.  Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.

Authors:  Eve Roman; Alex Smith; Simon Appleton; Simon Crouch; Richard Kelly; Sally Kinsey; Catherine Cargo; Russell Patmore
Journal:  Cancer Epidemiol       Date:  2016-04-16       Impact factor: 2.984

8.  Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms.

Authors:  Matteo Giaccherini; Angelica Macauda; Nicola Sgherza; Juan Sainz; Federica Gemignani; Josè Manuel Sanchez Maldonado; Manuel Jurado; Francesca Tavano; Grzegorz Mazur; Andrés Jerez; Joanna Góra-Tybor; Aleksandra Gołos; Francisca Hernández Mohedo; Joaquin Martinez Lopez; Judit Várkonyi; Raffaele Spadano; Aleksandra Butrym; Federico Canzian; Daniele Campa
Journal:  Blood Cancer J       Date:  2020-09-01       Impact factor: 11.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.